Population-Based Trends in Lung Cancer Incidence in Women

Seminars in Oncology

Volumn 36, Issue 6, 2009, Pages 506-515

  Egleston, Brian L ^a   Meireles, Sibele I ^a   Flieder, Douglas B ^a   Clapper, Margie L ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CAUSE OF DEATH; CULTURAL FACTOR; EPIDEMIC; ETHNIC DIFFERENCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; LUNG CANCER; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION EXPOSURE; SECOND CANCER; SMOKING; VIRUS CARCINOGENESIS; WART VIRUS;

AGE DISTRIBUTION; ENVIRONMENTAL POLLUTANTS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PAPILLOMAVIRUS INFECTIONS; SEER PROGRAM; SMOKING; SURVIVORS; UNITED STATES; WORLD HEALTH;

EID: 71049136597     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.09.003     Document Type: Article

References (84)

1. US Department of Health and Human Services. Women and smoking: a report of the surgeon general (2001), Public Health Service, Office of the Surgeon General, Washington, DC
2. American Cancer Society. Cancer facts and figures (2008), American Cancer Society, Atlanta, GA
3. Adebonojo S.A., Bowser A.N., Moritz D.M., and Corcoran P.C. Impact of revised stage classification of lung cancer on survival: a military experience. Chest 115 (1999) 1507-1513
4. Minami H., Yoshimura M., Miyamoto Y., Matsuoka H., and Tsubota N. Lung cancer in women: sex-associated differences in survival of patients undergoing resection for lung cancer. Chest 118 (2000) 1603-1609
5. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database. Incidence-SEER 9 Regs Limited-Use, Nov 2007 Sub (1973-2005) - Linked To County Attributes - Total U.S., 1969-2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission.
6. Surveillance Research Program. National Cancer Institute SEER*Stat software. wwwseercancergov/seerstat version 6.4.4.
7. International Agency for Research on Cancer. GLOBOCAN 2002 (2002), International Agency for Research on Cancer, Lyon, France
8. Alberg A.J., Ford J.G., and Samet J.M. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines. (2nd edition). Chest 132 (2007) 29S-55S
9. Bosetti C., Bertuccio P., Levi F., Lucchini F., Negri E., and La Vecchia C. Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol 19 (2008) 631-640
10. Levi F., Bosetti C., Fernandez E., Hill C., Lucchini F., Negri E., et al. Trends in lung cancer among young European women: the rising epidemic in France and Spain. Int J Cancer 121 (2007) 462-465
11. Toh C.-K. The changing epidemiology of lung cancer. Methods Mol Biol 472 (2009) 397-411
12. Sun S., Schiller J.H., and Gazdar A.F. Lung cancer in never smokers-a different disease. Nat Rev Cancer 7 (2007) 778-790
13. Bain C., Feskanich D., Speizer F.E., Thun M., Hertzmark E., Rosner B.A., et al. Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst 96 (2004) 826-834
14. Ernster V.L. Female lung cancer. Annu Rev Public Health 17 (1996) 97-114
15. Thun M.J., and Heath Jr. C.W. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev Med 26 (1997) 422-426
16. Morabia A., Costanza M.C., Bernstein M.S., and Rielle J.C. Ages at initiation of cigarette smoking and quit attempts among women: a generation effect. Am J Public Health 92 (2002) 71-74
17. Davy M. Time and generational trends in smoking among men and women in Great Britain, 1972-2004/05. Health Stat Q 32 (2006) 35-43
18. Sarna L., Bialous S.A., Jun H.J., Wewers M.E., Cooley M.E., and Feskanich D. Smoking trends in the Nurses' Health Study (1976-2003). Nurs Res 57 (2008) 374-382
19. Doll R., Gray R., Hafner B., and Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 280 (1980) 967-971
20. Stellman S.D., and Garfinkel L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst 76 (1986) 1057-1063
21. Hoffmann D., and Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 50 (1997) 307-364
22. Dresler C., Fratelli C., Babb J., Everley L.C., Evans A.A., and Clapper M.L. Gender differences in genetic susceptibility to lung cancer. Lung Cancer 30 (2000) 153-160
23. McDuffie H.H., Klaassen D.J., and Dosman J.A. Female-male differences in patients with primary lung cancer. Cancer 59 (1987) 1825-1830
24. International Early Lung Cancer Action Program Investigators. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 296 (2006) 180-184
25. Belani C.P., Marts S., Schiller J., and Socinski M.A. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 55 (2007) 15-23
26. Khuder S.A. Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer 31 (2001) 139-148
27. Freedman N.D., Leitzmann M.F., Hollenbeck A.R., Schatzkin A., and Abnet C.C. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 9 (2008) 649-656
28. Sridhar K.S., Thurer R.J., Markoe A.M., Chatoor H.T., Fountzilas G., Raub W.J., et al. Multidisciplinary approach to the treatment of locally and regionally advanced non-small cell lung cancer: University of Miami experience. Semin Surg Oncol 9 (1993) 114-119
29. Zell J.A., Ou S.H., Ziogas A., and Anton-Culver H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol 23 (2005) 8396-8405
30. Thun M.J., Hannan L.M., Adams-Campbell L.L., Boffetta P., Buring J.E., Feskanich D., et al. Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med 5 (2008) e185
31. Wakelee H.A., Chang E.T., Gomez S.L., Keegan T.H., Feskanich D., Clarke C.A., et al. Lung cancer incidence in never smokers. J Clin Oncol 25 (2007) 472-478
32. Boffetta P., Jarvholm B., Brennan P., and Nyren O. Incidence of lung cancer in a large cohort of non-smoking men from Sweden. Int J Cancer 94 (2001) 591-593
33. Enstrom J.E. Rising lung cancer mortality among nonsmokers. J Natl Cancer Inst 62 (1979) 755-760
34. Thun M.J., Henley S.J., Burns D., Jemal A., Shanks T.G., and Calle E.E. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 98 (2006) 691-699
35. Stellman S.D., Muscat J.E., Thompson S., Hoffmann D., and Wynder E.L. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer 80 (1997) 382-388
36. Thun M.J., Lally C.A., Flannery J.T., Calle E.E., Flanders W.D., and Heath Jr. C.W. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89 (1997) 1580-1586
37. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 (2004) 2129-2139
38. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 (2004) 1497-1500
39. Subramanian J., and Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 25 (2007) 561-570
40. Weiss J.M., Lacey Jr. J.V., Shu X.O., Ji B.T., Hou L., Yang G., et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 168 (2008) 1319-1325
41. Liu Y., Inoue M., Sobue T., and Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 117 (2005) 662-666
42. Kabat G.C., Miller A.B., and Rohan T.E. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 120 (2007) 2214-2220
43. Wysowski D.K., Golden L., and Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 85 (1995) 6-10
44. Kennedy D.L., Baum C., and Forbes M.B. Noncontraceptive estrogens and progestins: use patterns over time. Obstet Gynecol 65 (1985) 441-446
45. Hemminki E., Kennedy D.L., Baum C., and McKinlay S.M. Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86. Am J Public Health 78 (1988) 1479-1481
46. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
47. Beral V., Hermon C., Kay C., Hannaford P., Darby S., and Reeves G. Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study. BMJ 318 (1999) 96-100
48. Vessey M., Painter R., and Yeates D. Mortality in relation to oral contraceptive use and cigarette smoking. Lancet 362 (2003) 185-191
49. Taioli E., and Wynder E.L. Endocrine factors and adenocarcinoma of the lung in women. [letter]. J Natl Cancer Inst 86 (1994) 869-870
50. Ganti A.K., Sahmoun A.E., Panwalkar A.W., Tendulkar K.K., and Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 24 (2006) 59-63
51. Kreuzer M., Gerken M., Heinrich J., Kreienbrock L., and Wichmann H.E. Hormonal factors and risk of lung cancer among women?. Int J Epidemiol 32 (2003) 263-271
52. Schabath M.B., Wu X., Vassilopoulou-Sellin R., Vaporciyan A.A., and Spitz M.R. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 10 (2004) 113-123
53. Syrjanen K.J. Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration 38 (1979) 299-304
54. Giuliani L., Favalli C., Syrjanen K., and Ciotti M. Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature. Anticancer Res 27 (2007) 2697-2704
55. Bohlmeyer T., Le T.N., Shroyer A.L., Markham N., and Shroyer K.R. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol 18 (1998) 265-269
56. Brouchet L., Valmary S., Dahan M., Didier A., Galateau-Salle F., Brousset P., et al. Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 92 (2005) 743-746
57. Clavel C.E., Nawrocki B., Bosseaux B., Poitevin G., Putaud I.C., Mangeonjean C.C., et al. Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer 88 (2000) 1347-1352
58. Cook J.R., Hill D.A., Humphrey P.A., Pfeifer J.D., and El-Mofty S.K. Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: emerging common pattern of clinical features and human papillomavirus serotype association. Mod Pathol 13 (2000) 914-918
59. Guillou L., Sahli R., Chaubert P., Monnier P., Cuttat J.F., and Costa J. Squamous cell carcinoma of the lung in a nonsmoking, nonirradiated patient with juvenile laryngotracheal papillomatosis. Evidence of human papillomavirus-11 DNA in both carcinoma and papillomas. Am J Surg Pathol 15 (1991) 891-898
60. Jain N., Singh V., Hedau S., Kumar S., Daga M.K., Dewan R., et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 128 (2005) 3999-4007
61. Lele S.M., Pou A.M., Ventura K., Gatalica Z., and Payne D. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med 126 (2002) 1184-1188
62. Welt A., Hummel M., Niedobitek G., and Stein H. Human papillomavirus infection is not associated with bronchial carcinoma: evaluation by in situ hybridization and the polymerase chain reaction. J Pathol 181 (1997) 276-280
63. Yousem S.A., Ohori N.P., and Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 69 (1992) 693-697
64. Klein F, Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer Epub 2008 101016/jlungcan200810003. Available from wwwelseviercom/locate/lungcan.
65. Syrjanen K.J. HPV infections and lung cancer. J Clin Pathol 55 (2002) 885-891
66. Gorgoulis V.G., Zacharatos P., Kotsinas A., Kyroudi A., Rassidakis A.N., Ikonomopoulos J.A., et al. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 30 (1999) 274-283
67. Hirayasu T., Iwamasa T., Kamada Y., Koyanagi Y., Usuda H., and Genka K. Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol 49 (1996) 810-817
68. Miyagi J., Tsuhako K., Kinjo T., Iwamasa T., and Hirayasu T. Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan. J Clin Pathol 53 (2000) 676-684
69. Papadopoulou K., Labropoulou V., Davaris P., Mavromara P., and Tsimara-Papastamatiou H. Detection of human papillomaviruses in squamous cell carcinomas of the lung. Virchows Arch 433 (1998) 49-54
70. Tsuhako K., Nakazato I., Hirayasu T., Sunakawa H., and Iwamasa T. Human papillomavirus DNA in adenosquamous carcinoma of the lung. J Clin Pathol 51 (1998) 741-749
71. International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risks to humans. Vol. 90 Human papillomaviruses (2007), IARC, Lyon, France
72. Hsu N.Y., Cheng Y.W., Chan I.P., Ho H.C., Chen C.Y., Hsu C.P., et al. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer. Oncol Rep 21 (2009) 81-87
73. Sasco A.J., Secretan M.B., and Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45 Suppl 2 (2004) S3-S9
74. Czene K., Tiikkaja S., and Hemminki K. Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int J Cancer 105 (2003) 108-112
75. Sjodahl K., Jansson C., Bergdahl I.A., Adami J., Boffetta P., and Lagergren J. Airborne exposures and risk of gastric cancer: a prospective cohort study. Int J Cancer 120 (2007) 2013-2018
76. Pascual D., and Borque A. Epidemiology of kidney cancer. Adv Urol Epub (2008 November 4). http://www.hindawi.com 10.1155/2008/782381. Available from www.hindawi.com.
77. Laukkanen P., Koskela P., Pukkala E., Dillner J., Laara E., Knekt P., et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 84 (2003) 2105-2109
78. US Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. A report of the Surgeon General. DHHS publication no. (CDC) 89-8411 (1989), US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Washington, DC
79. Raymond J.S., and Hogue C.J. Multiple primary tumours in women following breast cancer, 1973-2000. Br J Cancer 94 (2006) 1745-1750
80. Matesich S.M., and Shapiro C.L. Second cancers after breast cancer treatment. Semin Oncol 30 (2003) 740-748
81. Roychoudhuri R., Evans H., Robinson D., and Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 91 (2004) 868-872
82. Bergfeldt K., Silfversward C., Einhorn S., and Hall P. Overestimated risk of second primary malignancies in ovarian cancer patients. Eur J Cancer 36 (2000) 100-105
83. Hulley S., Furberg C., Barrett-Connor E., Cauley J., Grady D., Haskell W., et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 288 (2002) 58-66
84. Beral V., Banks E., and Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 360 (2002) 942-944